Discuss your analysis

PHARMACEUTICAL PARTICLE IDENTIFICATION / PARENTERALS

Parenteral Particle Analysis & Control

Parenteral Particle Analysis & Control

Identify unexpected particles, characterize subvisible populations and develop methods for difficult-to-inspect products. Start with the particle question and the evidence your investigation needs.

Which particle question do you need to answer?

Visible Particle Defects & Investigations

What is the defect, what is it made of and what supports a probable-source investigation?

Explore visible particle investigations

Difficult-to-Inspect Products — method development

Subvisible Particle Characterization

Compare measured size distributions, material-class information and Raman-confirmed particle evidence.

Explore subvisible characterization

Shared analytical capabilities

Controlled sample preparation, calibrated microscopy, selected-particle Raman analysis and suitable reference comparisons connect the particle to reviewable evidence. Method development and validation are defined for the product and intended use.

Foreign Particle Investigation — a shared analytical service

Explore analytical services and method development

Packaging, components and in-process investigations

Compare materials and investigate particle findings from components, raw materials or process samples. The analytical scope depends on the material, sampling context and question.

Explore component and probable-source investigations

Discuss raw-material and in-process study scope

Explore the original measured evidence

The Subvisible page retains all three original A02 modules: size-class counts, chemical material-class comparison, and particle images with Raman spectra. The Visible page features the original cellulose-fiber reference study.

Particle size distributions from ten pharmaceutical autoinjector study samples, comparing particle counts across size classes from 2 µm to above 25 µm.

View A02 particle-population and Raman evidence

Explore cellulose-fiber source-tracing evidence

Brief regulatory orientation

Visible and subvisible studies sit in distinct inspection and analytical contexts. Select the pathway for concise source references; chemical particle evidence complements applicable compendial methods and supports the manufacturer’s investigation and control decisions.

Discuss your parenteral particle study

Tell us about the sample and intended outcome. We can help define the appropriate analytical next step.

Discuss your project